MSP Recovery (MSPR) sinks, falling 53% on its debut. Biote gets approval. Lots of extension votes ahead. And the rest of the day’s news in SPACs.

Medicare and Medicaid secondary payer reimbursement recovery specialist MSP Recovery (MSPR) begins trading tomorrow. Extension for TINV/Grindr. And the rest of the day’s news in SPACs.

Comera Life Sciences (CMRA), the maker of self-injectible biologics, deSPAC’d today, closing down 9%. An updated look at deSPAC count and redemption rates. And the rest of the day’s news in SPACs.

Another 2 SPAC DAs today, offset by some liquidations. And the rest of the day’s news in SPACs.

Amidst the ongoing market bloodbath, SPACs continue to march forward. LCAP gets approval for MSP Recovery. And the rest of the day’s news in SPACs.

As the market bounces back today, 2 more DAs in virtual reality and propTech. And the rest of the day’s news in SPACs.

Starting the week off with 2 DAs– oil & gas and battery tech. And the rest of the day’s news in SPACs.

Squeeze alert: OTRA approves its merger with Comera Life Sciences, albeit with some of highest redemptions we’ve seen in a while (98.4%). And the rest of the day’s news in SPACs.

SPAC deal for next-gen lithium ion battery maker Amprius Technologies. And the rest of the day’s news in SPACs.